About ANG Lifesciences India Ltd 
ANG Lifesciences India Ltd
Micro Cap
Pharmaceuticals & Drugs
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name "ANG Lifesciences India Private Limited" on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to "ANG Lifesciences India Private Limited" on September 22, 2010.
Company Coordinates 
Company Details
Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block Amritsar Punjab : 143001
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Capital Structure 
Present Equity Capital
INR 13.06 Cr
Number of Shares
1.31 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Nov-2022
1.31
13.06
100000
10
Preferential basis
13-Jul-2022
1.3
12.96
2591657
10
Bonus Issue
22-Sep-2021
1.04
10.37
5183315
10
Bonus Issue
08-Sep-2017
51.83
5.18
1500800
10
Public Issues
29-Mar-2010
36.83
3.68
150000
10
Allotment of Equity To Others
06-Jun-2008
35.33
3.53
289700
10
Allotment of Equity To Others
28-Mar-2008
32.43
3.24
2279449
10
Allotment of Equity To Others
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
44.8775
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Rajesh Gupta (70.41%)
Highest Public shareholder
None
Individual Investors Holdings
25.92%
Management
Designation
Remuneration
Rajesh Gupta
Managing Director
1.08 cr
Saruchi Gupta
Whole Time Director & CFO
47.25 lacs
Sukhpal Singh
Independent Director
60.0 k
Sudesh Kumari
Director
60.0 k
Pawanjit Singh
Independent Director
65.0 k
Chetna
Independent Director
35.0 k
Renu
Company Sec. & Compli. Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
88.8865
0%
Raw Materials Consumed
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Medicines
76.04
100.00%
Medicines
Revenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-5 Cr
Pharmaceuticals & Drugs
INR 38 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
1.14
-18.26%
0.54